Document is current
Any future updates will be listed below
-
Authors
Monette, Anne
Bergeron, Derek
Ben Amor, Amira
Meunier, Liliane
Caron, Christine
Mes-Masson, Anne-Marie
Kchir, Nidhameddine
Hamzaoui, Kamel
Jurisica, Igor
Lapointe, Réjean https://orcid.org/0000-0002-1871-5878
-
Funding
Funding for this research was provided by:
Canadian Cancer Society Research Institute (702036)
Quebec cell, tissue and gene therapy network –ThéCell (NA)
Terry Fox Research Institute (iTNT network)
Canadian Research Chair Program (#203373 and #225404)
Ontario Research Fund (GL2-01-030)
Natural Sciences and Engineering Research Council of Canada (203475)
Canada Foundation for Innovation (#12301, #203373, #29272, #225404, #30865)
Fonds de Recherche du Québec - Santé (NA, NA)
Mitacs (NA)
- License Information
-
More Information
Article History
Received: 24 September 2018
Accepted: 22 February 2019
First Online: 28 March 2019
Ethics approval and consent to participate
: Written and informed consent procedures were approved by the ethics review committees (La Rabta Hospital of Tunis, Tunis, Tunisia) and were obtained from patients prior to the collection of specimens. All experiments were performed at the Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Montréal, Canada, and the study was reviewed and approved by the local Institutional Review Board.
: Written informed consent was obtained from the patients for publication of their individual details and accompanying images in this manuscript. The consent form is held by the authors and is available for review by the Editor-in-Chief.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
